Glaukos and Avedro Announce Definitive Acquisition Agreement

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, and Avedro, Inc. (Nasdaq: AVDR), a leading hybrid ophthalmic pharmaceutical and medical technology company focused on treating corneal disease and disorders, today announced that the companies have entered into a [...]

By |2019-08-08T08:32:45-04:00August 8th, 2019|Dartmouth Innovation, News|

Evox Therapeutics Granted Key Exosome Patents

Evox Therapeutics has been granted three key patents by the United States Patent and Trademark Office (USPTO) and the European Patent Office (EPO). These three new grants are from one of several foundational patent families held by Evox and further reinforce the Company’s leading position within exosome-mediated RNA therapeutics and targeted exosome drug delivery. Read [...]

By |2019-08-07T12:14:28-04:00August 7th, 2019|News|